It functions by imitating the actions of GLP-1, or glucagon-like peptide-1, a hormone that is essential for controlling blood sugar levels
Engages the GIP receptor Targets glucose-dependent insulinotropic polypeptide a metabolic pathway most weight-management medications leave untouched
The upcoming SURMOUNT-MAINTAIN trial, expected to report results around mid-2026, will specifically compare the 5 mg maintenance dose against higher doses for weight maintenance after initial loss
In humans, 26 weeks of exenatide reduced brain response to alcohol cues in the ventral tegmental area 19
Additionally, through multiple pathwaysincluding ROS/NLRP3/Gasdermin D-mediated pyroptosis, endoplasmic reticulum stress, and autophagy inhibitionTMAO induces programmed death of intestinal epithelial cells (Liu et al., 2025)
Concomitantly, mean systolic blood pressure declines by 35 mmHg, with modest LDL improvements, providing biologically plausible support for downstream cardiovascular risk reduction